Market research
IDP.LSE InnovaDerma PLC
LSE GBP Consumer Defensive
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- 220
- Dividend yield
- 0.0%
- Beta
- 1.31
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- ISIN
- GB00BT9PTW34
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- 220
- Dividend yield
- 0.0%
- Beta
- 1.31
About
About InnovaDerma PLC
InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, the United States, Australasia, and the Asia Pacific region. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and hair removal wax and jelly, and shave and shower sorbet under the Nuthing brand. It also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan brand name; Prolong, a Class II medical device for the treatment of premature ejaculation; haircare products comprising shampoos, conditioners, and spray treatment for men and women to aid hair regrowth and hair thickening under the Roots brand name; and hair growth products under the GrowLase brand. The company sells its products through online and DTC channels. InnovaDerma PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the IDP.LSE discussion.
5 years, 5 months ago
InnovaDerma PLC is currently in a long term downtrend where the price is trading 23.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 0.5.
InnovaDerma PLC's total revenue sank by 0.0% to $3M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-135K since the same quarter in the previous year.
Finally, its free cash flow grew by 12.1% to $-531K since the same quarter in the previous year.
Based on the above factors, InnovaDerma PLC gets an overall score of 2/5.